MedPath

A clinical study to evaluate the effect of oral ayurvedic medication in treatment of renal calculus.

Phase 2/3
Not yet recruiting
Conditions
Urinary calculus, unspecified. Ayurveda Condition: ASMARI,
Registration Number
CTRI/2023/02/049762
Lead Sponsor
Tilak ayurved Mahavidyalaya
Brief Summary

Due to the sedentary lifestyle, unhealthy salt & mineral rich foods, bother to drink

plenty of water, digestive systems gets affected & tridoshas vitiated on reaching the

urinary tract causes ashmari which resembles the kidney stones & various urinary tract

disease. Available western medicines & techniques treat kidney stones with pain

killers, laser treatments, surgical removal which no doubt gives fast relief but on other

hand recurrence leading to long hospital stays rehospitalisation resulting in economical

loses.

Ayurveda the ancient science of life has explained various herbo mineral

remedies.Patala is one of them explained by Acharya Bhavprakash & Sushruta in

mutraghat chikitsa within easy to take cost effective & affordable to all socioeconomic

class.

In Ayurveda number of drugs and formulations are mentioned to treat

Mootrashmari, among them the patala kshar is selected for study as the drug is easily

available and can be given on O.P.D. basis.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
64
Inclusion Criteria
  • 1)Size of calculus- A known diagnosed case of renal calculus having calculus 5 to 7 mm.
    1. Age group -20 to 60 years with irrespective of gender.
  • 3)Patients ready to give written consent will be selected.
Exclusion Criteria
  • Patient who are suffering from severe systemic disorders like renal failure, Carcinoma .
  • Known case of DM, HTN, Asthma, HIV, HbsAg. 3.
  • Congenital anomalies of kidney.
  • The pregnant women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in symptoms of urolithiasis such as Abdominal pain, burning micturition, haematuria , also the site , size And number of ashmariBaseline , 7thday , 14th day, 21st day , 28th day
Secondary Outcome Measures
NameTimeMethod
Recurrence /Reappearance of symptoms of ashmari60 days

Trial Locations

Locations (1)

Seth Tarachand charitable ayurvedic hospital

🇮🇳

Pune, MAHARASHTRA, India

Seth Tarachand charitable ayurvedic hospital
🇮🇳Pune, MAHARASHTRA, India
Dr Shubham Kisan Mengade
Principal investigator
9922079243
mengadeshubham5@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.